Sampre Nutritions Faces Ongoing Challenges Amid Significant Stock Volatility and Decline

Mar 26 2025 11:06 AM IST
share
Share Via
Sampre Nutritions has faced significant volatility, reaching a new 52-week low and experiencing a notable decline over the past three days. The company's long-term fundamentals are weak, with negative operating profit growth and high debt levels, while institutional investor participation has decreased substantially.
Sampre Nutritions Faces Ongoing Challenges Amid Significant Stock Volatility and Decline
Sampre Nutritions, a microcap player in the FMCG sector, has experienced significant volatility today, hitting a new 52-week low of Rs. 23.03. This decline marks a continued downturn for the stock, which has underperformed its sector by 3.69% and has seen a consecutive fall over the past three days, resulting in a total drop of 12.65% during this period.
The company's long-term fundamentals appear weak, with a compound annual growth rate (CAGR) of operating profits at -1.41% over the last five years. Sampre Nutritions also faces challenges in servicing its debt, reflected in a high Debt to EBITDA ratio of 5.01 times. The Return on Equity (ROE) stands at a modest 1.71%, indicating low profitability relative to shareholders' funds. In terms of market performance, Sampre Nutritions has seen a staggering 65.76% decline over the past year, contrasting sharply with the Sensex's gain of 7.40%. The stock's technical indicators suggest a bearish trend, with multiple factors pointing to ongoing challenges. Additionally, institutional investor participation has dwindled, with a 50.06% reduction in stakes over the last quarter.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sampre Nutritions Ltd is Rated Sell
Jan 26 2026 10:10 AM IST
share
Share Via
Sampre Nutritions Ltd is Rated Sell
Jan 15 2026 10:10 AM IST
share
Share Via
Sampre Nutritions Ltd is Rated Sell
Jan 04 2026 10:10 AM IST
share
Share Via
Sampre Nutritions Ltd is Rated Sell
Dec 24 2025 08:23 PM IST
share
Share Via